Crinetics Pharmaceuticals Inc (CRNX)
R&D Expense Growth
-0.23%
Quarterly · Period ending:
CRNX R&D Expense Growth
Latest reported-0.23%period ending
Latest reported-0.23%period ending
CRNX Quarterly R&D Growth (QoQ) (0.00% → -0.23%)
Latest values, visible window
High-resolution chart · PNG
CRNX r&d expense growth history
Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | R&D Expense Growth |
|---|---|
| -0.2308% | |
| 17.669% | |
| -5.9814% | |
| 12.6561% | |
| 5.3266% | |
| 14.5329% | |
| 7.5293% | |
| 6.1035% | |
| 9.3793% | |
| 16.9169% | |
| 4.0694% | |
| 7.8716% | |
| 5.6463% | |
| 3.9929% | |
| 15.6439% | |
| -3.055% | |
| 16.7882% | |
| 14.8269% | |
| 13.4871% | |
| 4.8001% | |
| 17.2799% | |
| 4.8069% | |
| 22.8557% | |
| 8.6619% | |
| -9.0535% | |
| 14.1563% | |
| 2.7066% | |
| 14.9538% | |
| 41.7643% | |
| -5.1758% | |
| 11.1095% | |
| 31.8652% | |
| 10.6356% | |
| 84.2311% | |
| 1.5458% | |
| 21.1234% | |
| 0.8717% | |
| 0% |